NCT00859534View on ClinicalTrials.gov

Phase II Solar Urticaria (SU) Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions
Solar Urticaria
Interventions
DRUG

afamelanotide

16mg afamelanotide, one dose for the duration of the clincial trial

Trial Locations (1)

Unknown

Salford Royal Foundation Hospital (Hope Hospital), Manchester

Sponsors
All Listed Sponsors
lead

Clinuvel Pharmaceuticals Limited

INDUSTRY